Overview

Pharmacokinetic-Pharmacodynamic Relationship of Metformin in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Two doses of metformin with 12 hour interval - low dose group (375/250 mg) - high dose group (1000/1000mg)
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Metformin